NCBI PubMed Central
open access
Gut Microbial Metabolism Inactivates Trifluridine and Drives Loss of Anticancer Efficacy.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Intestinal Microbiota and Antimicrobial Resistance#184890
- Image 5_Cross-sectional gut microbiota and serum metabolite differences across clinically defined groups in colorectal cancer.tif#353678
- A metagenomic survey of global antimicrobial resistance#373116
- Effects of Resistant Potato Starch on the Gut Microbiota#1046146
- Gut microbiota-derived metabolites target C5AR1/KDM2A/HCAR3 axis in inflammatory bowel disease: a multi-machine learning algorithms and molecular docking study.#662772
Record · ID 1346522
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive